alanylalanine and alpha-aspartylalanine

alanylalanine has been researched along with alpha-aspartylalanine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandsch, M; Gebauer, S; Hartrodt, B; Knütter, I; Neubert, K; Thondorf, I1
Collantes, ER; Dunn, WJ1
Scozzafava, A; Supuran, CT1
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I1

Other Studies

4 other study(ies) available for alanylalanine and alpha-aspartylalanine

ArticleYear
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
    Journal of medicinal chemistry, 2003, Dec-18, Volume: 46, Issue:26

    Topics: Carrier Proteins; Dipeptides; Drug Design; Ligands; Models, Molecular; Molecular Conformation; Peptide Transporter 1; Protein Binding; Quantitative Structure-Activity Relationship; Symporters

2003
Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues.
    Journal of medicinal chemistry, 1995, Jul-07, Volume: 38, Issue:14

    Topics: Amino Acid Sequence; Amino Acids; Bradykinin; Electrochemistry; Molecular Sequence Data; Peptides; Structure-Activity Relationship; Taste

1995
Carbonic anhydrase activators: human isozyme II is strongly activated by oligopeptides incorporating the carboxyterminal sequence of the bicarbonate anion exchanger AE1.
    Bioorganic & medicinal chemistry letters, 2002, Apr-22, Volume: 12, Issue:8

    Topics: Anion Exchange Protein 1, Erythrocyte; Binding Sites; Carbonic Anhydrases; Enzyme Activation; Enzyme Activators; Humans; Isoenzymes; Models, Molecular; Oligopeptides

2002
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
    Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

    Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters

2005